A Case of Postoperative Peritoneal Dissemination Recurrence of CY1 Gastric Cancer with cCR after Nab-PTX Therapy
A 72-year-old man visited his local doctor for gastric discomfort. Esophagogastroduodenoscopy revealed a type 3 tumor on the gastric antrum, and histopathological examination revealed a moderately differentiated adenocarcinoma(tub2). The patient was referred to our hospital and CT scan revealed wall thickening with contrast effect in the gastric angle but no enlarged lymph nodes in the region. The patient was diagnosed as cT3N0M0, Stage ⅡB gastric cancer and underwent open distal gastrectomy and D2 lymph node dissection. No peritoneal dissemination was observed, but intraoperative laparoscopic cytology showed Class Ⅴ. The patient was diagnosed as CY1 Stage Ⅳ gastric cancer, and treated with S-1 plus Tmab therapy starting 1 month after surgery. One year postoperative follow-up CT revealed recurrence of peritoneal disseminations, and the patient was treated with nab-PTX as a second-line therapy. Tumor shrinkage was achieved steadily, and the peritoneal disseminations disappeared at the CT after 12 courses, resulting in cCR. Thereafter, cCR continued and treatment was terminated at the 17th course. Seven years have passed since the end of chemotherapy, and the patient is still alive without recurrence.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
---|---|
Enthalten in: |
Gan to kagaku ryoho. Cancer & chemotherapy - 50(2023), 13 vom: 01. Dez., Seite 1884-1886 |
Sprache: |
Japanisch |
---|
Beteiligte Personen: |
Watanabe, Atsuhiro [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 12.02.2024 Date Revised 12.02.2024 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM367926075 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367926075 | ||
003 | DE-627 | ||
005 | 20240213232907.0 | ||
007 | tu | ||
008 | 240202s2023 xx ||||| 00| ||jpn c | ||
028 | 5 | 2 | |a pubmed24n1291.xml |
035 | |a (DE-627)NLM367926075 | ||
035 | |a (NLM)38303240 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a jpn | ||
100 | 1 | |a Watanabe, Atsuhiro |e verfasserin |4 aut | |
245 | 1 | 2 | |a A Case of Postoperative Peritoneal Dissemination Recurrence of CY1 Gastric Cancer with cCR after Nab-PTX Therapy |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 12.02.2024 | ||
500 | |a Date Revised 12.02.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A 72-year-old man visited his local doctor for gastric discomfort. Esophagogastroduodenoscopy revealed a type 3 tumor on the gastric antrum, and histopathological examination revealed a moderately differentiated adenocarcinoma(tub2). The patient was referred to our hospital and CT scan revealed wall thickening with contrast effect in the gastric angle but no enlarged lymph nodes in the region. The patient was diagnosed as cT3N0M0, Stage ⅡB gastric cancer and underwent open distal gastrectomy and D2 lymph node dissection. No peritoneal dissemination was observed, but intraoperative laparoscopic cytology showed Class Ⅴ. The patient was diagnosed as CY1 Stage Ⅳ gastric cancer, and treated with S-1 plus Tmab therapy starting 1 month after surgery. One year postoperative follow-up CT revealed recurrence of peritoneal disseminations, and the patient was treated with nab-PTX as a second-line therapy. Tumor shrinkage was achieved steadily, and the peritoneal disseminations disappeared at the CT after 12 courses, resulting in cCR. Thereafter, cCR continued and treatment was terminated at the 17th course. Seven years have passed since the end of chemotherapy, and the patient is still alive without recurrence | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
700 | 1 | |a Yamamoto, Yuji |e verfasserin |4 aut | |
700 | 1 | |a Yanagawa, Senichiro |e verfasserin |4 aut | |
700 | 1 | |a Takaya, Momoko |e verfasserin |4 aut | |
700 | 1 | |a Amioka, Jun |e verfasserin |4 aut | |
700 | 1 | |a Kaneko, Yuki |e verfasserin |4 aut | |
700 | 1 | |a Nishina, Mai |e verfasserin |4 aut | |
700 | 1 | |a Mashima, Hiroaki |e verfasserin |4 aut | |
700 | 1 | |a Sumi, Yusuke |e verfasserin |4 aut | |
700 | 1 | |a Yamaki, Minoru |e verfasserin |4 aut | |
700 | 1 | |a Kurayoshi, Manabu |e verfasserin |4 aut | |
700 | 1 | |a Oshita, Akihiko |e verfasserin |4 aut | |
700 | 1 | |a Nakahara, Masahiro |e verfasserin |4 aut | |
700 | 1 | |a Noriyuki, Toshio |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Gan to kagaku ryoho. Cancer & chemotherapy |d 1993 |g 50(2023), 13 vom: 01. Dez., Seite 1884-1886 |w (DE-627)NLM012601861 |x 0385-0684 |7 nnns |
773 | 1 | 8 | |g volume:50 |g year:2023 |g number:13 |g day:01 |g month:12 |g pages:1884-1886 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 50 |j 2023 |e 13 |b 01 |c 12 |h 1884-1886 |